Effectiveness and Cost-effectiveness of the Energetic Program

November 6, 2017 updated by: Radboud University Medical Center

Energetic, a Self Management Group Program Aimed at Reconditioning and Social Participation in Persons With a Muscle Disease; a Multicentre Randomized Controlled Trial.

Fatigue is present in at least 60% of the patients with a muscle disease and can be the most disabling symptom. In combination with other impairments, this often results in low levels of physical activity and decreased social participation, leading to large societal costs. Energetic is a self-management group program aimed at improving participation and physical endurance in these patients. Our hypothesis is that Energetic results in improved participation and improved physical endurance, less experienced fatigue and better quality of life compared to usual care, without increasing health care costs.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gelderland
      • Nijmegen, Gelderland, Netherlands
        • Radboudumc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • formal diagnosis of muscular disease, either FascioScapuloHumeral Dystrophy (FSHD), Inclusion Body Myositis (IBM), Mitochondrial Myopathy (MM) or any other;
  • being severely fatigued
  • being cardiopulmonary stable and capable of aerobic training (as determined using a submaximal cycling exercise test with ECG (electrocardiography) and advice from a consultant cardiologist and pulmonologist);
  • being motivated, committed to the program, and 'ready to change' which is discussed with the patient during the screening by a rehabilitation physician and an occupational therapist; to this end, motivational interviewing will be used (including a advantages/disadvantages matrix; a visual analogue scale (VAS) to rate the importance of participation in de program; and a VAS to rate the confidence a patient has that participation in the program is feasible)
  • being able to formulate at least 3 individual participation goals during the interview with the occupational therapist.

Exclusion Criteria:

  • active depression or other psychiatric disorder as indicated by a consultant psychologist or by the medical history,
  • pregnancy,
  • severe co-morbid condition,
  • having participated in the Energetic program before
  • a travel distance perceived as too burdensome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Energetic
Self management group program aimed at reconditioning and social participation
Physiotherapy and occupational therapy aimed at reconditioning and social participation.
Other: Control group
Usual care
Usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Canadian Occupational Performance Measure (COPM)
Time Frame: 3 months
Perceived activity performance. Three months will be the primary analysis. Effects at follow up will be measured at 6 and 12 months (see secondary outcome measures) (patient)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Activity Card Sort (ACS)
Time Frame: 3 months
Participation measure:% retained activities.(patient)
3 months
Canadian Occupational Performance Measure (COPM-satisfaction)
Time Frame: 3 months
Perceived satisfaction with performance (patient)
3 months
Canadian Occupational Performance Measure (COPM-satisfaction)
Time Frame: 6 months
Perceived satisfaction with performance (patient)
6 months
Canadian Occupational Performance Measure (COPM-satisfaction)
Time Frame: 15 months
Perceived satisfaction with performance (patient)
15 months
Canadian Occupational Performance Measure (COPM-performance)
Time Frame: 6 months
Perceived performance in activities. Is primary outcome measure at 3 months, but data of 6 and 15 months follow up wil be used in a secondary analysis. (patient)
6 months
Canadian Occupational Performance Measure (COPM-performance)
Time Frame: 15 months
Perceived performance in activities. Is primary outcome measure at 3 months, but data of 6 and 15 months follow up wil be used in a secondary analysis. (patient)
15 months
Activity Card Sort (ACS)
Time Frame: 6 months
Participation measure:% retained activities.(patient)
6 months
Activity Card Sort (ACS)
Time Frame: 15 months
Participation measure:% retained activities.(patient)
15 months
Six Minutes Walking Test (6MWT)
Time Frame: 3 months
physical endurance, sub-max test. (patient)
3 months
Six Minutes Walking Test (6MWT)
Time Frame: 6 months
physical endurance, sub-max test. (patient)
6 months
Six Minutes Walking Test (6MWT)
Time Frame: 15 months
physical endurance, sub-max test. (patient)
15 months
Health care cost
Time Frame: 3 months
Evaluation health care cost (patient)
3 months
Health care cost
Time Frame: 6 months
Evaluation health care cost (patient)
6 months
Health care cost
Time Frame: 15 months
Evaluation health care cost (patient)
15 months
Checklist Individual Strength subscale fatigue (CIS-fatigue)
Time Frame: 3 months
Impact of fatigue (patient)
3 months
Checklist Individual Strength subscale fatigue (CIS-fatigue)
Time Frame: 6 months
Impact of fatigue (patient)
6 months
Checklist Individual Strength subscale fatigue (CIS-fatigue)
Time Frame: 15 months
Impact of fatigue (patient)
15 months
Health-related Quality of Life: Short Form 36 (SF-36)
Time Frame: 3 months
Quality of life, used for evaluation of cost effectiveness (patient)
3 months
Health-related Quality of Life: Short Form 36 (SF-36)
Time Frame: 6 months
Quality of life, used for evaluation of cost effectiveness (patient)
6 months
Health-related Quality of Life: Short Form 36 (SF-36)
Time Frame: 15 months
Quality of life, used for evaluation of cost effectiveness (patient)
15 months
General Self-Efficacy Scale
Time Frame: 3 months
Evaluation of the perceived self-efficacy (patient)
3 months
General Self-Efficacy Scale
Time Frame: 6 months
Evaluation of the perceived self-efficacy (patient)
6 months
General Self-Efficacy Scale
Time Frame: 15 months
Evaluation of the perceived self-efficacy (patient)
15 months
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 3 months
Anxiety and depression (patient)
3 months
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 6 months
Anxiety and depression (patient)
6 months
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 15 months
Anxiety and depression (patient)
15 months
Zarit Burden Inventory (ZBI)
Time Frame: 3 months
Perceived caregiver burden (caregiver)
3 months
Zarit Burden Inventory (ZBI)
Time Frame: 6 months
Perceived caregiver burden (caregiver)
6 months
Zarit Burden Inventory (ZBI)
Time Frame: 15 months
Perceived caregiver burden (caregiver)
15 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Edith Cup, dr., Radboudumc, department Rehabilitation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

November 1, 2016

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

August 4, 2014

First Submitted That Met QC Criteria

August 4, 2014

First Posted (Estimate)

August 5, 2014

Study Record Updates

Last Update Posted (Actual)

November 7, 2017

Last Update Submitted That Met QC Criteria

November 6, 2017

Last Verified

April 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuromuscular Diseases

Clinical Trials on Control group

Subscribe